Status:
COMPLETED
Trial for People With Established Type 2 Diabetes During Ramadan
Lead Sponsor:
University of Leicester
Collaborating Sponsors:
University Hospitals, Leicester
University Hospital Birmingham
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
Dual therapy with metformin and Liraglutide is more effective at helping people with established Type 2 Diabetes Mellitus (T2DM) observing Ramadan achieve a triple composite endpoint of weight reducti...
Detailed Description
Participants in the control arm will essentially continue with their standard routine care and those in the intervention groups will either receive Liraglutide in addition to metformin or those on dua...
Eligibility Criteria
Inclusion
- Individuals ≥ 18 years old with established T2DM on metformin only
- or dual therapy of metformin plus a sulphonylurea or pioglitazone
- with a HbA1c between 7 - 11 % if on monotherapy and between 6.5 - 12% if on dual therapy
Exclusion
- Are pregnant or breast feeding
- Suffer from terminal illness
- Have significant renal or liver impairment
- Are unable to provide informed consent
- Have severe and enduring mental health problems
- Are not primarily responsible for their own care
- Are receiving insulin therapy
- Type 1 diabetes
Key Trial Info
Start Date :
April 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
99 Patients enrolled
Trial Details
Trial ID
NCT02292290
Start Date
April 1 2011
End Date
December 1 2012
Last Update
January 30 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospitals of Leicester
Leicester, Leicestershire, United Kingdom
2
University Hospital Birmingham
Birmingham, West Midlands, United Kingdom